Clinical Trials Directory

Trials / Completed

CompletedNCT04871360

Effect of L-Citrulline Supplementation on NAFLD in Adolescents With Obesity

Effect of Oral L-Citrulline Supplementation on Liver Function and Non-Alcoholic Fatty Liver Disease in Adolescents With Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
Universidad de Guanajuato · Academic / Other
Sex
All
Age
15 Years – 19 Years
Healthy volunteers
Not accepted

Summary

One of the comorbidities of obesity is nonalcoholic fatty liver disease (NAFLD). L-citrulline is a non-protein amino acid that has shown positive effects on the degree of fat retention and metabolic profile in NAFLD. The objective is to assess the effect of oral L-citrulline supplementation on liver function and nonalcoholic fatty liver in adolescents with obesity. A clinical study will be carried out in 40 adolescents (15-19 years) with obesity, they will be divided into a control group that will receive a placebo and an experimental group that will receive 6 g of l-citrulline per day for eight weeks.

Detailed description

It is hypothesized that l-citrulline supplementation decreases liver enzymes and the degree of hepatic steatosis in adolescents with obesity. The aim of the study is to assess the effect of oral L-citrulline supplementation on liver function and nonalcoholic fatty liver in adolescents with obesity. A prospective randomized, double-blind clinical study will be carried out in 40 adolescents (15-19 years) with obesity, they will be divided into a control group that will receive a placebo (carboxymethyl cellulose) and an experimental group that will receive 6 g of pure l-citrulline per day per eight weeks. At the beginning and end of the intervention, anthropometric, biochemical and metabolic data will be evaluated, as well as tests of function and degree of hepatic steatosis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTL-Citrulline supplementThe intervention will consist of oral supplementation of six grams of pure l-citrulline for eight weeks.
DIETARY_SUPPLEMENTCarboxymethyl cellulose supplementThe intervention will consist of oral carboxymethyl cellulose supplementation as a placebo.

Timeline

Start date
2021-05-05
Primary completion
2021-12-19
Completion
2022-01-15
First posted
2021-05-04
Last updated
2022-01-19

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04871360. Inclusion in this directory is not an endorsement.